2-165294040-A-AAATT
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The ENST00000283256(SCN2A):c.-147_-146insAATT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00073 ( 0 hom., cov: 11)
Exomes 𝑓: 0.000040 ( 0 hom. )
Consequence
SCN2A
ENST00000283256 5_prime_UTR
ENST00000283256 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.275
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000734 (76/103550) while in subpopulation NFE AF= 0.00101 (53/52458). AF 95% confidence interval is 0.000793. There are 0 homozygotes in gnomad4. There are 41 alleles in male gnomad4 subpopulation. Median coverage is 11. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 76 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN2A | NM_001040142.2 | c.-51-1733_-51-1732insAATT | intron_variant | ENST00000375437.7 | NP_001035232.1 | |||
SCN2A | NM_001371246.1 | c.-51-1733_-51-1732insAATT | intron_variant | ENST00000631182.3 | NP_001358175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000283256 | c.-147_-146insAATT | 5_prime_UTR_variant | 1/27 | 1 | ENSP00000283256.6 | ||||
SCN2A | ENST00000375437.7 | c.-51-1733_-51-1732insAATT | intron_variant | 5 | NM_001040142.2 | ENSP00000364586.2 | ||||
SCN2A | ENST00000631182.3 | c.-51-1733_-51-1732insAATT | intron_variant | 5 | NM_001371246.1 | ENSP00000486885.1 | ||||
SCN2A | ENST00000424833.5 | c.-51-1733_-51-1732insAATT | intron_variant | 1 | ENSP00000406454.2 |
Frequencies
GnomAD3 genomes AF: 0.000734 AC: 76AN: 103514Hom.: 0 Cov.: 11
GnomAD3 genomes
AF:
AC:
76
AN:
103514
Hom.:
Cov.:
11
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000399 AC: 21AN: 526586Hom.: 0 Cov.: 0 AF XY: 0.0000286 AC XY: 7AN XY: 244830
GnomAD4 exome
AF:
AC:
21
AN:
526586
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
244830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000734 AC: 76AN: 103550Hom.: 0 Cov.: 11 AF XY: 0.000856 AC XY: 41AN XY: 47874
GnomAD4 genome
AF:
AC:
76
AN:
103550
Hom.:
Cov.:
11
AF XY:
AC XY:
41
AN XY:
47874
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Early Infantile Epileptic Encephalopathy, Autosomal Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Seizures, benign familial infantile, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at